Co-Sponsored by the Johns Hopkins & University of Maryland Baltimore Institutes for Clinical & Translational Research   To attend, contact Molly Lutz at 410-328-2488 or mlutz@som.umaryland.edu. Links: CATALiST Seminar Series  University of Maryland Baltimore Institute for Clinical and Translational Research      

Two page proposal submission deadline is February 16th. The competition is open for student teams (graduate and undergraduate) across three (3) tracks – Advanced Health, Global Health and Health IT. Prize money: 1st Prize: $4,000 2nd Prize: $3,000 3rd Prize: $2,000  For additional information, visit the links below. Center for Bioengineering Innovation & Design Website Download Flyer Design Competition Details Project Submission Form

Venous thromboembolism (VTE) is a disorder that includes deep vein thrombosis and pulmonary embolism. A deep vein thrombosis (DVT) occurs when a blood clot forms in a deep vein, usually in the lower leg, thigh, or pelvis. A pulmonary embolism (PE) occurs when a clot breaks loose and travels through the bloodstream to the lungs. In 2008, Johns Hopkins professor of pediatrics and medicine Neil Goldenberg, MD, PhD (at the time, a faculty member of University of Colorado School of Medicine) submitted an investigator-initiated trial (IIT) award application to the pharmaceutical company that oversaw research and development of the low […]

The deadline for proposals is Sunday, March 1 by 5 pm. The JHU Claude D. Pepper Older Americans Independence Center (OAIC) is seeking proposals from faculty researchers for studies on frailty in older Americans, with discovery aimed at impacting the larger field of frailty science, as articulated in the attached requests for proposals. There are four award opportunities: Research Education Core Funding for Junior Faculty ($35,000 direct costs) Pilot/Exploratory Studies Core Funding ($30,000 direct costs) Biostatistics Core Development Project Funding ($35,000 direct costs) Biological Mechanisms Development Project Funding ($35.000 direct costs) Successful applicants will receive salary, research core support, and […]

This year’s event will feature interactive panel discussions and more: Shortening the diagnostic odyssey. Individualized therapies and personalized medicine. Expanding and improving access to rare diseases knowledge. Inspiring stories through TED-style talks. NIH Town Hall question and answer session. NIH clinical trial resources. Posters and exhibits by rare disease groups and researchers. Artwork and tours of the NIH Clinical Center and the National Library of Medicine. Admission is free, and the event is open to the public, including patients, patient advocates, health care providers, researchers, industry representatives and government employees. In association with Global Genes®, participants are encouraged to wear their favorite […]

Notice Number: NOT-OD-20-057 Beginning January 1, 2020, through an agreement between the National Institutes of Health (NIH) and the Centers for Disease Control (CDC) National Center for Health Statistics, (NCHS), NIH will reimburse the NCHS National Death Index (NDI) for the costs of NIH-supported investigators to link their research databases with the NDI for the research aims supported by the NIH. “NIH-supported investigators” refers to extramural investigators actively funded by the NIH, contract investigators working under an active contract with the NIH, and intramural researchers employed by the NIH. These NIH-supported investigators will be able to link their research data […]

Do you need help getting your research ideas patented? You are invited to join a webinar co-hosted by the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) and the United States Patent and Trademark Office (USPTO) on January 29, 2020 at 1 p.m. ET. Lili Portilla, director of the NCATS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, will provide insights to help biotech researchers and entrepreneurs understand intellectual property (IP) protection and navigate the Federal Drug Administration (FDA) regulatory approval pathways, which are steps required for the commercialization of new promising […]

The Kids-DOTT trial, led by Neil Goldenberg, MD, PhD, began enrollment in 2007. The last days and hours of 2019 marked not only the end of a decade, but also the completion of patient enrollment in a landmark randomized clinical trial on the duration of anti-clotting medication (anticoagulant) therapy for venous thromboembolism (VTE) in patients under 21 years old — the Kids-DOTT trial. VTE, which includes blood clots in the deep veins of the legs, arms, other areas of the body, including those that travel to (or originate in) the arteries of the lungs, occurs in only about 1 in […]

Clinical Research by Learning from Practice: Facilitating through Technology and Collaboration Register: https://2020jhcrntrends.eventbrite.com   Keynote: James Williams, PhD, MHS Senior Director, Global Networks – Medical Evidence, Research, and Innovation at Biogen   Panelists: Ellen Mowry, MD Associate Professor of Neurology Johns Hopkins School of Medicine Peter Zandi, PhD. MPH, MH Professor Johns Hopkins Bloomberg School of Public Health, Diana Gumas, MS, IT Sr. IT Director Johns Hopkins School of Medicine   More Information: https://ictr.johnshopkins.edu/JHCRN Daniel Lunz dlunz1@jhu.edu

On behalf of Johns Hopkins University and Johns Hopkins Medicine, the Office of Foundation Relations helps manage institutional relationships with a number of private foundations (both nationally-focused and regionally-focused) that fund higher education and research initiatives. The Foundation is seeking highly innovative and groundbreaking medical research proposals from top tier institutions in both basic biological and applied research that will have the greatest impact on scientific knowledge and human health. Proposals should be distinctive and novel in their approaches, question the prevailing paradigm, and lead to advancement of knowledge in the field. A highly qualified scientific advisory committee will review […]

Blocking second protein could lead to better treatment   In a recent study using mice, lab-grown human retinal cells and patient samples, Johns Hopkins Medicine scientists say they found evidence of a new pathway that may contribute to degeneration of the light sensitive tissue at the back of the eye. The findings, they conclude, bring scientists a step closer to developing new drugs for a central vision-destroying complication of diabetes that affects an estimated 750,000 Americans. The Johns Hopkins research team focused on diabetic macular edema, a form of swelling and inflammation that occurs in people with diabetes when blood vessels […]